CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
1-Year Return
31.81%
This Quarter Return
+16%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$324M
AUM Growth
+$28.5M
(+9.6%)
Cap. Flow
-$70.4K
Cap. Flow
% of AUM
-0.02%
Top 10 Holdings %
Top 10 Hldgs %
32.96%
Holding
465
New
18
Increased
159
Reduced
244
Closed
13
Top Buys
| 1 |
Vanguard World Funds Extended Duration ETF
EDV
|
$3.28M |
| 2 |
Tesla
TSLA
|
$2.24M |
| 3 |
Apple
AAPL
|
$2.14M |
| 4 |
Meta Platforms (Facebook)
META
|
$2.1M |
| 5 |
Vaxcyte
PCVX
|
$2M |
Top Sells
| 1 |
iQIYI
IQ
|
$4.85M |
| 2 |
Amazon
AMZN
|
$4.7M |
| 3 |
Airbnb
ABNB
|
$3.2M |
| 4 |
Analog Devices
ADI
|
$2.94M |
| 5 |
KE Holdings
BEKE
|
$1.93M |
Sector Composition
| 1 | Technology | 41.8% |
| 2 | Consumer Discretionary | 21.38% |
| 3 | Healthcare | 19.26% |
| 4 | Communication Services | 6.74% |
| 5 | Financials | 4.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Amicus Therapeutics
FOLD
$2.46B
| $46.8K | 0.01% |
3,730
-77
| -2% | -$967 |
|
202
Old Dominion Freight Line
ODFL
$31.7B
| $45.8K | 0.01% |
248
+182
| +276% | +$33.6K |
|
203
Exelon
EXC
$43.9B
| $45.7K | 0.01% |
1,122
+821
| +273% | +$33.4K |
|
204
Paychex
PAYX
$48.7B
| $45.5K | 0.01% |
407
+298
| +273% | +$33.3K |
|
|
RETA
205
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $44.1K | 0.01% |
433
-2
| -0.5% | -$204 |
|
206
Vir Biotechnology
VIR
$732M
| $43.1K | 0.01% |
1,756
-53
| -3% | -$1.3K |
|
207
Ultragenyx Pharmaceutical
RARE
$3.07B
| $42.8K | 0.01% |
928
-23
| -2% | -$1.06K |
|
208
GE HealthCare
GEHC
$34.6B
| $41.7K | 0.01% |
+513
| New | +$41.7K |
|
209
Axsome Therapeutics
AXSM
$6.25B
| $41K | 0.01% |
571
-18
| -3% | -$1.29K |
|
210
CoStar Group
CSGP
$37.9B
| $41K | 0.01% |
461
+338
| +275% | +$30.1K |
|
211
Cytokinetics
CYTK
$6.34B
| $40.9K | 0.01% |
1,254
-28
| -2% | -$913 |
|
212
Electronic Arts
EA
$42.2B
| $39.9K | 0.01% |
308
+225
| +271% | +$29.2K |
|
213
GlobalFoundries
GFS
$18.5B
| $39.9K | 0.01% |
618
+453
| +275% | +$29.3K |
|
214
Krystal Biotech
KRYS
$4.35B
| $39.8K | 0.01% |
339
-10
| -3% | -$1.17K |
|
215
PTC Therapeutics
PTCT
$4.55B
| $39.5K | 0.01% |
972
-28
| -3% | -$1.14K |
|
216
Beam Therapeutics
BEAM
$2.11B
| $39.4K | 0.01% |
1,235
+18
| +1% | +$575 |
|
217
Xcel Energy
XEL
$43B
| $38.9K | 0.01% |
621
+455
| +274% | +$28.5K |
|
218
Fastenal
FAST
$55.1B
| $38K | 0.01% |
1,288
+942
| +272% | +$27.8K |
|
219
Insmed
INSM
$30.7B
| $37.7K | 0.01% |
1,788
-60
| -3% | -$1.27K |
|
220
Cognizant
CTSH
$35.1B
| $37.4K | 0.01% |
573
+419
| +272% | +$27.4K |
|
221
Revolution Medicines
RVMD
$7.57B
| $37.3K | 0.01% |
1,393
+167
| +14% | +$4.47K |
|
222
Verisk Analytics
VRSK
$37.8B
| $36.8K | 0.01% |
163
+116
| +247% | +$26.2K |
|
|
SAGE
223
DELISTED
Sage Therapeutics
SAGE
| $36.8K | 0.01% |
783
-26
| -3% | -$1.22K |
|
224
Amphastar Pharmaceuticals
AMPH
$1.37B
| $36.4K | 0.01% |
633
-22
| -3% | -$1.26K |
|
225
BridgeBio Pharma
BBIO
$10.2B
| $36.2K | 0.01% |
2,104
+54
| +3% | +$929 |
|